GLP1R and Alzheimer disease: Whereas brain weight [12, 13], hippocampal insulin [13–16], cortical glucose levels or brain GLUT1 and GLUT4 [13] do not seem to be affected, LRGT treatment increases GLP1-receptors in the hippocampus of AD mice [15–17].